DACOGEN

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, South Africa, Spain, Turkey, UK, United States.

Active ingredients

The drug DACOGEN contains one active pharmaceutical ingredient (API):

1	Decitabine UNII 776B62CQ27 - DECITABINE
	Decitabine is a cytidine deoxynucleoside analogue that selectively inhibits DNA methyltransferases at low doses, resulting in gene promoter hypomethylation that can result in reactivation of tumour suppressor genes, induction of cellular differentiation or cellular senescence followed by programmed cell death.
	Read more about Decitabine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DACOGEN Powder for concentrate for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01BC08	Decitabine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues
Discover more medicines within L01BC08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	514507501170311
EE	Ravimiamet	1595583
ES	Centro de información online de medicamentos de la AEMPS	112792001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	146466
GB	Medicines & Healthcare Products Regulatory Agency	215216
HK	Department of Health Drug Office	63484, 67129
IL	מִשְׂרַד הַבְּרִיאוּת	6562
LT	Valstybinė vaistų kontrolės tarnyba	1067906
NL	Z-Index G-Standaard, PRK	103764
PL	Rejestru Produktów Leczniczych	100289486
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W59587001
TR	İlaç ve Tıbbi Cihaz Kurumu	8699593775048
US	FDA, National Drug Code	59148-046
ZA	Health Products Regulatory Authority	46/26/0608